Findings from a 3-year analysis demonstrated that among patients treated with tirzepatide, 98.8% remained diabetes free.

Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with ...

“The technology is now changing people’s lives,” Shen said.

Discover Patanjali’s Madhugrit, an Ayurvedic diabetes solution blending natural herbs with scientific research to manage ...

The collaboration between NABH and RSSDI seeks to elevate diabetes care quality by establishing robust accreditation ...

Novo Nordisk has launched Wegovy – its popular weight loss treatment – in China. China, with a population of 1.4 billion, has ...

The holidays are near, and so is the season of eating decadent meals – and sometimes, overeating. Overindulging on food is ...

For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study ...

In a statement at the launch, Managing Director of Reyada Medical Centre, Jamsheer Hamza, expressed, “The ‘No Diabetes’ ...

Consuming honey and black pepper during winter works like medicine. Many problems can be cured by licking black pepper mixed ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Hypochondria can, in extreme cases, leave people unable to hold down a job or make it impossible for them to leave the house, ...